Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Merck KGaA returns Biomira's Theratope

Merck KGaA (FSE:MRK) returned to Biomira (TSE:BRA; BIOM) the development and commercialization rights

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE